Author:
Lee Jeffrey E.,Abdalla Joseph,Porter Geoffrey A.,Bradford Loretta,Grimm Elizabeth A.,Reveille John D.,Mansfield Paul F.,Gershenwald Jeffrey E.,Ross Merrick I.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.J Clin Oncol 1999;17:1–8.
2. Topalian SL, Rivoltini L, Mancini M, et al. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.Proc Natl Acad Sci U S A 1994;91:9461–5.
3. Becker JC, Brabletz T, Czerny C, Termeer C, Brocker EB. Tumor escape mechanisms from immunosurveillance: induction of unresponsiveness in a specific MHC-restricted CD4+ human T cell clone by the autologous MHC class II+ melanoma.Int Immunol 1993;5:1501–8.
4. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.Nat Genet 1994;6:157–62.
5. Uno H, Kawano K, Matsuoka H, Tsuda K. HLA and adult T cell leukaemia. HLA-linked genes controlling susceptibility to human T cell leukaemia virus type I.Clin Exp Immunol1988;71:211–6.